Cardiff Oncology Inc (CRDF)

Feb 25, 2025

Cardiff Oncology Inc expected to post a loss of 24 cents a shareEarnings Preview - TradingView

Feb 25, 2025

Feb 24, 2025

Cardiff Oncology to Present at Upcoming Investor Conferences - The Manila Times

Feb 24, 2025

Feb 24, 2025

Can Cardiff Oncology's New Colorectal Cancer Approach Transform Treatment? CEO to Reveal Strategy - StockTitan

Feb 24, 2025

Feb 23, 2025

Critical Contrast: Cardiff Oncology (NASDAQ:CRDF) versus Vir Biotechnology (NASDAQ:VIR) - Defense World

Feb 23, 2025

Feb 22, 2025

Cardiff Oncology (CRDF) to Release Earnings on Thursday - Defense World

Feb 22, 2025

Feb 20, 2025

Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update - The Manila Times

Feb 20, 2025

Feb 20, 2025

Can Cardiff Oncology's Q4 Earnings Reveal New Cancer Drug Progress? - StockTitan

Feb 20, 2025

Feb 20, 2025

Bullish Cardiff Oncology Insiders Rewarded As Their Investment Rises To US$1.81m - Simply Wall St

Feb 20, 2025

Feb 19, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Growth in Short Interest - MarketBeat

Feb 19, 2025

Feb 19, 2025

Taking on analysts’ expectations and winning: Cardiff Oncology Inc (CRDF) - SETE News

Feb 19, 2025

Feb 18, 2025

Cardiff Oncology: Pioneering RAS-Mutated Cancer Therapies With Onvansertib (NASDAQ:CRDF) - Seeking Alpha

Feb 18, 2025

Feb 18, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Increase in Short Interest - Defense World

Feb 18, 2025

Feb 14, 2025

SG Americas Securities LLC Sells 6,103 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Feb 14, 2025

Feb 13, 2025

Compass Therapeutics (NASDAQ:CMPX) & Cardiff Oncology (NASDAQ:CRDF) Critical Review - Defense World

Feb 13, 2025

Feb 12, 2025

Cardiff Oncology Inc (CRDF) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle

Feb 12, 2025

Feb 11, 2025

Cardiff Oncology Inc (CRDF) produces promising results - US Post News

Feb 11, 2025

Feb 10, 2025

Metastatic Prostate Cancer Clinical and Non-Clinical Studies, - openPR

Feb 10, 2025

Feb 07, 2025

Cardiff Oncology Inc (CRDF) Beta Value: Understanding the Market Risk - The News Heater

Feb 07, 2025

Feb 06, 2025

Get in on Cardiff Oncology Inc’s (CRDF) buy-in window today! - SETE News

Feb 06, 2025

Feb 06, 2025

Cardiff Oncology Inc (CRDF) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Feb 06, 2025

Feb 06, 2025

BlackRock, Inc. Expands Stake in Cardiff Oncology Inc. - GuruFocus.com

Feb 06, 2025

Feb 05, 2025

Quarterly Snapshot: Quick and Current Ratios for Cardiff Oncology Inc (CRDF) - The Dwinnex

Feb 05, 2025

Feb 04, 2025

Analysts review Cardiff Oncology Inc’s rating - Knox Daily

Feb 04, 2025

Feb 04, 2025

Cardiff Oncology Inc (CRDF)’s results reveal risk - US Post News

Feb 04, 2025

Jan 29, 2025

Protara Therapeutics (NASDAQ:TARA) vs. Cardiff Oncology (NASDAQ:CRDF) Head-To-Head Review - Defense World

Jan 29, 2025

Jan 26, 2025

HB Wealth Management LLC Invests $105,000 in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jan 26, 2025

Jan 26, 2025

Assenagon Asset Management S.A. Sells 203,292 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jan 26, 2025

Jan 26, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Jan 26, 2025

Jan 24, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Position Boosted by Barclays PLC - Defense World

Jan 24, 2025

Jan 21, 2025

If You Don’t Buy Cardiff Oncology Inc (NASDAQ: CRDF) Now, You’ll Kick Yourself Later - Stocks Register

Jan 21, 2025

Jan 15, 2025

Jane Street Group LLC Cuts Stake in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jan 15, 2025

Jan 08, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares Acquired by Geode Capital Management LLC - Defense World

Jan 08, 2025

Jan 08, 2025

Barclays PLC Purchases 39,542 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jan 08, 2025

Jan 07, 2025

Cardiff Oncology updates bylaws, changes fiscal year - Investing.com India

Jan 07, 2025

Jan 07, 2025

Cardiff Oncology Inc (NASDAQ: CRDF) Is A Buzzing Hot Stock - Stocks Register

Jan 07, 2025

Jan 06, 2025

Cardiff Oncology updates bylaws, changes fiscal year By Investing.com - Investing.com South Africa

Jan 06, 2025

Jan 02, 2025

State Street Corp Purchases 27,628 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jan 02, 2025

Dec 31, 2024

Short Interest in Cardiff Oncology, Inc. (NASDAQ:CRDF) Expands By 21.6% - MarketBeat

Dec 31, 2024

Dec 26, 2024

Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook - GlobeNewswire

Dec 26, 2024

Dec 25, 2024

Institutions along with individual investors who hold considerable shares inCardiff Oncology, Inc. (NASDAQ:CRDF) come under pressure; lose 27% of holdings value - Simply Wall St

Dec 25, 2024

Dec 23, 2024

While institutions own 25% of Cardiff Oncology, Inc. (NASDAQ:CRDF), retail investors are its largest shareholders with 57% ownership - Yahoo Finance

Dec 23, 2024

Dec 20, 2024

Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024

Dec 18, 2024

Cardiff Oncology CFO James Levine purchases $36,725 in shares By Investing.com - Investing.com Canada

Dec 18, 2024

Dec 18, 2024

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Dec 18, 2024

Dec 16, 2024

Cardiff Oncology, Inc. (NASDAQ:CRDF) Short Interest Update - MarketBeat

Dec 16, 2024

Dec 15, 2024

Piper Sandler Boosts Cardiff Oncology (NASDAQ:CRDF) Price Target to $10.00 - Defense World

Dec 15, 2024

Dec 14, 2024

Undercovered Dozen: Ubiquiti, Ready Capital, Cardiff Oncology, Vodafone + - Seeking Alpha

Dec 14, 2024

Dec 14, 2024

Cardiff Oncology price target raised to $10 from $7 at Piper Sandler - Yahoo Finance

Dec 14, 2024

Dec 13, 2024

Cardiff Oncology (NASDAQ:CRDF) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat

Dec 13, 2024